Mayo Clinic researchers are working to improve diagnosis and treatment of hypertrophic cardiomyopathy. Specific efforts involve the study of the genetic causes of HCM as well as potential new diagnostic and treatment tools. Mayo researchers have made important discoveries in the genetics of hypertrophic cardiomyopathy, including the identification of five new HCM-susceptibility genes.
Read more about research in Mayo's Division of Cardiovascular Diseases and in the Sudden Death Genomics Laboratory.
See a list of publications by Mayo Clinic doctors on hypertrophic cardiomyopathy on PubMed, a service of the National Library of Medicine.
Feb. 22, 2014
- Maron MS, et al. Overview of hypertrophic cardiomyopathy management including treatment of special problems http://www.uptodate.com/home. Accessed Sept. 26, 2013.
- AskMayoExpert. What tests are needed to confirm the diagnosis of hypertrophic cardiomyopathy (HCM), and what is the role of genetic testing? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Bonow RO, et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa.: Mosby Elsevier; 2012. Accessed Sept. 26, 2013.
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Sept. 26, 2013.
- Jacoby DL, et al. Hypertrophic cardiomyopathy: Diagnosis, risk stratification and treatment. Canadian Medical Association Journal. 2013;185:127.
- Gersh BJ, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761.
- Hypertrophic cardiomyopathy. American Heart Association. http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_312225.pdf. Accessed Sept. 28, 2013.
- Ommen SR (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 3, 2013.